TLR4 and neoplasm: Research by Jie Xu and colleagues showed that SeNPs significantly activated the Tlr4/Myd88/NF-κB signaling pathway, leading to the conversion of M2 macrophages into M1 macrophages and effectively stimulating an anti-tumor immune response in mice with the H22 tumor model (122).